Gross Profit Margin (Quarterly) Chart

View Gross Profit Margin (Quarterly) for IMCC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit Margin (Quarterly) Chart
Start Trial

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 19.83%
March 31, 2026 16.35%
December 31, 2025 0.52%
September 30, 2025 19.72%
June 30, 2025 26.98%
March 31, 2025 27.58%
December 31, 2024 20.10%
September 30, 2024 22.68%
June 30, 2024 5.72%
March 31, 2024 14.75%
December 31, 2023 7.86%
September 30, 2023 21.38%
June 30, 2023 26.17%
Date Value
March 31, 2023 23.18%
December 31, 2022 18.00%
September 30, 2022 13.78%
June 30, 2022 17.33%
March 31, 2022 32.45%
December 31, 2021 1.36%
September 30, 2021 -6.36%
June 30, 2021 -23.27%
March 31, 2021 61.92%
December 31, 2020 -149.6%
September 30, 2020 57.05%
June 30, 2020 53.90%
March 31, 2020 47.09%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
InterCure Ltd. --
Teva Pharmaceutical Industries Ltd. 52.07%
RedHill Biopharma Ltd. --
MediWound Ltd. 10.90%
Purple Biotech Ltd. --

Gross Profit Margin (Quarterly) Related Metrics